Article

Mechanisms of superior respiratory IgA responses against SARS-CoV-2 after mucosal vaccination

2025-09-22

Abstract excerpt

<h4>Summary</h4> Mucosal immunization and respiratory IgA offer significant promise in protecting against airborne pathogens, including SARS-CoV-2. However, the conditions and mechanisms that lead to the robust induction of respiratory IgA responses following mucosal vaccination remain poorly understood. It is also currently debatable whether mucosal vaccination is still warranted given that most individuals in d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ebd2d0c9-a867-57c5-9812-8f624da879b1
DOI: 10.1101/2025.09.22.677712

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Mechanisms of superior respiratory IgA responses against SARS-CoV-2 after mucosal vaccinationDOI 10.1101/2025.09.22.677712Read

Long-term respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccinationSemantic proximity Read

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic RNA-mucosal adenoviral vector immunizationSemantic proximity Read

Long-term respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccinationSemantic proximity Read

Single-dose respiratory mucosal delivery of next-generation viral-vectored COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2Semantic proximity Read

Prime-pull immunization of mice with a BcfA-adjuvanted vaccine elicits mucosal immunity and prevents SARS CoV-2 infection and pathologySemantic proximity Read

Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2Semantic proximity Read

Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in miceSemantic proximity Read

Phase 1 Study of Safety, Reactogenicity, and Immunogenicity of a Novel MVA-SARS-2-ST Vaccine Candidate Administered as Inhalation Boost in SARS-CoV-2 Immunized AdultsSemantic proximity Read

Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infectionSemantic proximity Read

Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccinationSemantic proximity Read

Unadjuvanted intranasal spike vaccine booster elicits robust protective mucosal immunity against sarbecovirusesSemantic proximity Read

Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primatesSemantic proximity Read